<p>The subject of the invention is an avirulent antirabies vaccine, and consists of an avirulent mutant of a strain SAD of the rabies virus whose glyoprotein has, in position 333, a naturally occurring amino acid whose codon differs from those for arginine by at least two nucleotides. Application: vaccination against rabies.</p>